FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
27 | Real-world data for malignant melanoma stage II adjuvant therapy Silvana Cozzolino1, Antonino Colloca1, Miriam Forte1, Francesco Caraglia1, Alfonso Esposito1, Maria Cristina Giugliano1, Eleonora Cioli1, Marcella Scala2, Maria Chiara Sergi3, Teresa Del Giudice4, Francesca Sparano5, Immacolata Paciolla6, Mariangela Pasqualoni7, Luigi Formisano2, Stefania Napolitano1, Antonio Maria Grimaldi1, Paolo Antonio Ascierto5, Fortunato Ciardiello1, Teresa Troiani1, Vincenzo De Falco1 | 1Medical Oncology, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples; 2Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy; 3Division of Medical Oncology, "Mons. A.R. Dimiccoli" Hospital, Barletta; 4Nuclear Medicine Unit, "Mater Domini" University Hospital, Catanzaro; 5Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples; 6Medical Oncology Unit, AORN "San Pio", Benevento, Italy; 7Medical Oncology Unit, ASL Taranto, Italy.
326 -
Mendelian randomization analysis of the causal relationship between immune cells and keloid
694PDF: 376SUPPLEMENTARY MATERIAL: 134HTML: 12 -
Successfully maintained complete remission of mycosis fungoides by umbilical cord blood transplantation: a case report and literature review
421PDF: 261SUPPLEMENTARY MATERIAL: 29HTML: 4 -
12 | Integrated molecular and immunophenotypic profiling of uveal melanoma: prognostic insights and biological perspectives Francesco Fortarezza1, Giovanni Zarrilli2, Giada Munari1, Valentina Angerilli3, Mariangela Balistreri1, Luisa Piccin4, Valentina Salizzato4, Jacopo Pigozzo4, Giulia Midena5, Raffaele Parrozzani6, Valentina Guarneri4|7, Edoardo Midena5|6, Marta Sbaraglia1|8, Matteo Fassan8|9, Angelo Paolo Dei Tos1|8 | 1Surgical Pathology and Cytopathology Unit, Department of Integrated Diagnostics. Azienda Ospedale-Università Padova, Padua; 2Surgical Pathology Unit, Azienda Ulss 3 Serenissima, Ospedale dell'Angelo, Venezia; 3Department of Surgical Pathology, Azienda ULSS2 Marca Trevigiana, Treviso; 4Medical Oncology 2, Veneto Institute of Oncology, IOV-IRCCS, Padua; 5IRCCS-Fondazione Bietti, Rome; 6Department of Ophthalmology, University of Padova, Padova; 7Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua; 8Department of Medicine, University of Padua School of Medicine, Padua; 9Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
298 -
36 | Neoadjuvant strategy for locally advanced conjunctival melanoma: a single-center approach to eye preservation F. Rifaldi1|2, M. Angi3, L. Giuseppe1, F. Lanza3, A. Spagnoletti1, J. Sergenti3, A. Indini1, E. Mastrogiuseppe3, M. Del Vecchio1, L. Di Guardo1 | 1Melanoma Medical Oncology Unit, Department of Medical Oncology ed Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; 2Fondazione IRCCS Policlinico San Matteo, Pavia; 3Ocular Oncology Service, Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
363 -
21 | Melanoma in situ: long-term outcomes and follow-up strategies based on risk stratification Beatrice De Checchi1, Paolo del Fiore2, Irene Russo2, Chiara Trevisiol2, Marco Domenico Mazza2, Saveria Tropea2, Francesco Russano2, Mauro Alaibac3, Carlomaria Gianesini4, Giovanni Madeo4, Simone Mocellin2|4 | 1Department of Medicine, University of Padua, Padua; 2Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; 3Department of Dermatology, University of Padua; 4Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
299 -
04 | Association of a novel TERT polymorphism with poorer survival in male patients with melanoma Fortunato Cassalia1, Maria Santa Rocca2, Andrea Di Nisio3, Paolo del Fiore*4, Clara Benna5|7, Ilaria Cosci6, Simone Mocellin4|5, Alberto Ferlin*2|6 | 1Department of Dermatology, University of Padua, Padua; 2Unit of Andrology and Reproductive Medicine, University Hospital of Padua, Padua; 3Department of Wellbeing, Nutrition and Sport, Pegaso Telematic University, Naples; 4Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; 5Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua; 6Department of Medicine, University of Padua, Padua; 7Unit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Padua, Italy.
332 -
A bibliometric study of the top 100 most cited articles on melanoma: insights into research trends and characteristics
381PDF: 192SUPPLEMENTARY MATERIAL: 119 -
Dermatitis artefacta: a challenging diagnosis
460PDF: 232HTML: 23 -
Application of ChatGPT as a content generation tool in continuing medical education: acne as a test topic
1160PDF: 649SUPPLEMENTARY MATERIAL: 120HTML: 17 -
06 | SUNTEL program: first experience of school integration of the ugly duckling sign with e-learning and peer education for melanoma awareness Giorgia Ravaglia1, Serena Magi2, Elisabetta Costa3, Matelda Medri2, Franca Gentilini4, Chiara Scutellà4, Daniela De Zerbi5, Silvia Gerosa1, Federica Zamagni6, Chiara Doccioli7, Sara Gandini8, Maria Costanza Cipullo9, Saverio Caini7, Ignazio Stanganelli1|2 | 1Dermatology Resident Training Program, Department of Medicine and Surgery, University of Parma, Parma; 2Skin Cancer Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" – IRST Meldola, Forlì-Cesena; 3Graphic Design and Multimedia "Good Sun Good Skin" project, Istituto Oncologico Romagnolo, Forlì; 4IOR Scuola, Istituto Oncologico Romagnolo, Forlì; 5Scientific High School "Alfredo Oriani", Ravenna; 6Emilia-Romagna Cancer Registry, Romagna Unit, IRCCS IRST Romagnolo Institute for the Study of Tumors "Dino Amadori", Meldola, Forlì-Cesena; 7Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention, and Clinical Network, ISPRO, Florence; 8Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan; 9Directorate General for Student Affairs, Inclusion, and Career Guidance, Prevention and Health Education Unit, Ministry of Education, Rome, Italy.
323 -
Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols
782PDF: 297SUPPLEMENTARY MATERIAL: 75HTML: 4 -
24 | Management of advanced basal cell carcinoma with hedgehog inhibitors: a real-world prospective comparative study Federico Venturi1|2|3, Biancamaria Zuccaro1, Gabriella Perillo1, Giovanni Cecchi1, Aurora Gaeta4|5, Sara Gandini4, Vincenzo De Giorgi1|6 | 1Section of Dermatology, Department of Health Sciences, University of Florence; 2Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna; 3Department of Medical and Surgical Sciences, DIMEC, Alma Mater Studiorum University of Bologna; 4Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan; 5Department of Statistics and Quantitative Methods, University of Milano-Bicocca; 6Cancer Research "Attilia Pofferi" Foundation, Pistoia, Italy.
290 -
Cutaneous myiasis complicating squamous cell carcinoma: a case report with literature review
681PDF: 372SUPPLEMENTARY MATERIAL: 26VIDEO 1: 114VIDEO 2: 103HTML: 10
